Success Stories | Synaps DX

Providing healthcare professionals with the necessary scientific data to identify Alzheimer’s Disease and distinguish it from other dementias - because being in doubt is simply not acceptable.

This test was developed, and its performance characteristics determined by NeuroDiagnostics Inc, dba Synaps Dx. It has not been cleared or approved by the U.S. Food and Drug Administration. NeuroDiagnostics, Inc. is regulated under the Clinical Laboratory Improvement Amendments (CLIA) as an accredited laboratory to perform high complexity clinical testing. The test is intended for patients with dementia. Test results should be interpreted in conjunction with other laboratory and clinical data available to the clinician. All rights reserved.